Read More Pharma Industry News Horizon Therapeutics announces $3.05bn acquisition of Viela Bio to expand rare disease pipeline In a major move to strengthen its leadership in rare diseases, Horizon Therapeutics, an Irish biopharmaceutical company, has… bypharmanewsdailyFebruary 1, 2021